COMMAND – EFS: Implantable BCI to Control a Digital Device for People with Paralysis, ENVI-RCT – Envi-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke, SEARCH – A Randomized Controlled Trial Comparing Surgiscopic Evacuation of Intracerebral Hemorrhage Versus Standard of Care Medical Management, TORNADO – Treatment of Ruptured Wide-Neck Aneurysms with Nautilus Device Assisted Occlusion, ATHENA – A PROSPECTIVE, RANDOMIZED, DUAL-ARM, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF MECHANICAL THROMBECTOMY USING THE ANACONDA ANA5 DEVICE IN COMBINATION WITH A STENT RETRIEVER (ANA2401), DIRECT – Delay Avoiding Primary Evaluation for Thrombectomy for Acute Stroke Patients with Large Vessel Occlusion in the Angiography Suite (DIRECT) Trial, PIANO – p48/64 MW HPC in Aneurysm Occlusion (PCT-002-23), RP Pivotal – The Pivotal Study of RapidPulseTM Aspiration System as Frontline Approach for Patients with Acute Ischemic Stroke due to Large Vessel Occlusions, REACH - Rapid Evacuation and Access of Cerebral Hemorrhage (REACH) Trial, STRIDE – Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Normal Pressure Hydrocephalus, BE-SILENT – Safety & Performance of the BosSTENT in the Treatment of Cerebral Venous Sinus Stenosis, ENDOLOW - Endovascular Therapy for Low NIHSS lschemic Strokes- (Clinical Project Manager), ESCAPE-NEXT - A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis, SENSE-005 - A Prospective, Non-randomized, Sequentially-enrolled, Multi-center, Phase II Study to Evaluate the SENSE Device’s Ability to Detect and Monitor Traumatic Brain Injury, CLEAR – A protective, open-label, multi-center, single-arm trial design to assess the safety, performance and efficacy of the NeVaTM Stent Retriever in the treatment of large vessel occlusion strokes, ELEVATE – Evaluate Endovascular treatment of Acutely ruptured shallow intradural aneurysms with the PipelineTM Flex Embolization Device with Shield TechnologyTM, EMBOLISE – Embolization of the Middle Meningeal Artery with ONYXTM liquid Embolic System in the Treatment of Subacute and Chronic Subdural Hematoma, PROST – pREST for Occlusive Strome Treatment, STRIP - Thromboembolism Registry of Imaging and Pathology, SAHaRA - Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome: A Randomized Controlled Trial, CBCT IIS - Image-guided Therapy for Stroke Intervention (co-investigator), C3PO - Clinical-trial of COVID-19 Convalescent Plasma in Outpatients, PACT - Prehospital Airways Control Trial, BOOST-3 - Brain Oxygen Optimization in Severe TBI, Phase 3, STEM - The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma, Discovery of Biomarker Signatures Prognostic for Neuropathic Pain after Acute Spinal Cord Injury, A Study of the Pipeline Flex Embolization Device with Shield Technology for Endovascular Treatment of Wide-Necked Intracranial Aneurysms, Vitamin C, Thiamine, and Steroids in Sepsis, CHARM - A phase 11, double-blinded, randomized, placebo-controlled study to evaluate efficacy, safety and tolerability of BAF312 in patients with stroke due to intracerebral hemorrhage, SEPSIS-SHIELD - HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients with Suspected Infections, IMPERATIVE - A randomized, controlled, multi-center clinical investigation to evaluate and compare the safety and efficacy of using 2 QOM reperfusion catheters and stent retrievers in thrombectomy procedures to treat acute ischemic stroke patients, INSPIRE - Randomized, Controlled, Single-blind Study of Probable Benefit of the Neuro-Spina/ Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care, ICECAP - Influence of Cooling duration on Efficacy in Cardiac Arrest Patients, TED - The Traumatic Brain Injury: Friend Controls Study; leveraging the infrastructure of Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TB/): and funded by the TB/ Endpoints Development (TED) Initiative, Fibromuscular dysplasia in patients with acute ischemic stroke, TRACK-TBI - Transforming Research and Clinical Knowledge in Traumatic Brain Injury, ENRICH - Early Minimally-invasive Removal of ICH, ASTRAL - A Multicenter; Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion., Plasma and exosomal protein biomarker discovery for stroke, Association of Non-Contrast CT Imaging Characteristics of Clots in Acute Ischemic Stroke with Clinical and Procedural Outcomes, ALADIN: Automated Large Artery Occlusion Detection IN Stroke, Stroke/TIA Re-occurrence in Medically Managed Symptomatic Intracanal Stenosis Predictive Factors, and Response to Medical vs. Endovascular Therapy, Artificial Intelligence for Neuroimaging Parametric Analysis in Stroke, Evaluation of Long-Term Outcomes of Endovascular Therapy in Acute Stroke Patients, Neuroimaging Parametric Approaches - Retrospective characterization of neuroimaging parametric approaches in CNS disease, FAST-ED Scale Performance in a Mobile Stroke Unite, CoBIS2 - Phase 2 Study of Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke, ESCAPE-NA 1 - A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy, P-CARE Aim 3 - Patient-Centered Approaches to Research Enrollment Decisions in Acute Cardiovascular Disease- Intervention Phase, ARISE II - Analysis of Revascularization in Ischemic Stroke with EmboTrap, CoBIS - Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke, SAFETY AND EFFICACY OF ENDOVASCULAR TREATMENT WITHIN 6 HOURS IN NON-ELIGIBLE PATIENTS FOR INTRAVENOUS t-PA, CORDIS ENTERPRISE Vascular Reconstruction Device (VRD) and Delivery System (DS)-Humanitarian Device Exemption, DAWN - DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention, Georgia StrokeNet Patient Registry, STRATIS Registry- Systematic Evaluation of Patients Treated with Neurothrombectomy Devices for Acute Ischemic Stroke Registry, TREVO Registry - Prospective, open-label, consecutive enrollment, multi-center; international registry to assess real world performance of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in subjects experiencing ischemic stroke., MiSPACE - Minimally invasive Subcortical Parafascicular Access for Clot Evacuation, Stroke Awareness and Perceived Risk Survey, NeuSTART - Neuroprotection with Stalin Therapy for Acute Recovery Trial Phase 2, Stroke Imaging Parameters - Retrospective Analysis of Imaging Findings and Clinical Impact in Acute Ischemic Stroke, Sulcal Effacement With Preserved Gray-White Junction: A Sign of Reversible Ischemia, Wingspan System Post Market Surveillance Humanitarian Device Exemption, Carotid artery elongation and the risk of dissection in acute ischemic stroke intervention, SWIFT PRIME - Solitaire FR with the Intention For Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke Clinical Trial, Aldagen ALD-401 - A Phase 2 Randomized, Controlled Study with a Phase 1 Safety Cohort testing ALD-401 Derived from Autologous Bone Marrow Delivered via Intracarotid Infusion in Subjects with Ischemic Stroke with Blinded Assessments., ReCCLAIM - Cooling after Endovascular Reperfusion in Ischemic Stroke Patients, PENUMBRA 3D - A randomized, concurrent controlled trial to assess the safety and effectiveness of the Separator 3D as a component of the Penumbra System in the revascularization of large vessel occlusion in acute ischemic stroke, DIAS 4 - A randomized, double-blind, parallel-group placebo-controlled phase III study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke, TREVO 2 - Thrombectomy Revascularization of large Vessel Occlusions in acute ischemic stroke, The THERAPY Trial: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke, CRISP - CT perfusion to predict Response to recanalization in Ischemic Stroke Project